
Singapore's non-oil domestic exports unexpectedly contracted 4.6% year-on-year in July, missing analyst forecasts and reversing June's gain, primarily driven by a decline in pharmaceuticals. This weaker performance signals a potential slowdown in the second half of 2025, aligning with government warnings that export frontloading to mitigate US tariffs is tapering. Prime Minister Lawrence Wong underscored persistent concerns regarding the 10% US tariff baseline and the broader global rise in trade barriers, posing ongoing challenges for small, open economies.
Singapore's non-oil domestic exports (NODX) registered a significant and unexpected contraction of 4.6% year-over-year in July, starkly missing the consensus forecast of a 1.8% decline and reversing the revised 12.9% expansion seen in June. The downturn was primarily attributed to weakness in the non-electronics segment, with pharmaceuticals leading the drop. This data point provides the first concrete evidence supporting official warnings of a second-half slowdown, as the effects of export frontloading to mitigate U.S. tariffs begin to wane. Despite this negative trade signal, the government recently upgraded its full-year 2025 GDP growth forecast to a range of 1.5% to 2.5%, citing a stronger-than-expected first half. However, persistent geopolitical risks remain a key concern, as highlighted by Prime Minister Lawrence Wong's statements regarding the uncertainty of the current 10% U.S. tariff and the potential for future targeted duties on critical sectors like pharmaceuticals and semiconductors, posing a structural headwind for the trade-dependent economy.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately negative
Sentiment Score
-0.40